These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32556651)

  • 61. A history of Clostridioides difficile infection portends infection recurrence and worse outcomes after stoma reversal.
    Lynch KT; Cramer CL; Kane WJ; Hedrick T; Friel C; Vemuru S; Hoang SC
    Surgery; 2021 Jul; 170(1):55-60. PubMed ID: 33546931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Kim D; Yoo ER; Li AA; Tighe SP; Cholankeril G; Ahmed A
    Dig Dis Sci; 2021 Jan; 66(1):296-307. PubMed ID: 32124196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Temporal trends of inpatient
    Sumon ZE; Lesse AJ; Sellick JA; Tetewsky S; Mergenhagen KA
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):44-51. PubMed ID: 31708000
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A decade of Clostridioides difficile infection: a constant challenge to maintain the status quo.
    Skally M; Bennett K; Burns K; Brennan R; Finn C; O'Connell K; Dinesh B; O'Donnell S; Fawley W; Wilcox M; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2023 May; 135():59-66. PubMed ID: 36863458
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology of Primary and Recurrent Healthcare-Associated and Community-Associated Pediatric Clostridioides difficile Infection in Canada, 2015-2020.
    Silva A; Du T; Choi KB; Pelude L; Golding GR; Hizon R; Lee BE; Chow B; Srigley JA; Hota SS; Comeau JL; Thampi N;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):222-225. PubMed ID: 36718660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.
    Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM
    Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in Healthcare Facility-Onset Clostridioides difficile Infection and the Impact of Testing Schemes in an Acute Care Hospital System in New York City, 2016-2019.
    Episcopia B; Gupta A; Fornek M; Kaminski M; Malik S; Sunny S; Landman D; Xavier G; Quale J
    Am J Infect Control; 2021 Oct; 49(10):1262-1266. PubMed ID: 33716096
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inpatient fluoroquinolone use in Veterans' Affairs hospitals is a predictor of
    Silva SY; Wilson BM; Redmond SN; Donskey CJ
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):57-62. PubMed ID: 32962774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis.
    Dubberke ER; Olsen MA; Stwalley D; Kelly CP; Gerding DN; Young-Xu Y; Mahé C
    PLoS One; 2016; 11(2):e0146822. PubMed ID: 26859403
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between Socioeconomic Status and Incidence of Community-Associated Clostridioides difficile Infection - United States, 2014-2015.
    Skrobarcek KA; Mu Y; Ahern J; Basiliere E; Beldavs ZG; Brousseau G; Dumyati G; Fridkin S; Holzbauer SM; Johnston H; Kainer MA; Meek J; Ocampo VLS; Parker E; Perlmutter R; Phipps EC; Winston L; Guh A
    Clin Infect Dis; 2021 Aug; 73(4):722-725. PubMed ID: 33462596
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Successful management of a Clostridioides difficile ribotype 027 outbreak with a lean intervention bundle.
    Kuenzli AB; Burri S; Casanova C; Sommerstein R; Buetti N; Seth-Smith HMB; Bodmer T; Egli A; Marschall J
    J Hosp Infect; 2020 Oct; 106(2):240-245. PubMed ID: 32745592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Three-year epidemiological analysis of Clostridioides difficile infection and the value of hospital-infection control measures in a tertiary-care teaching hospital in Japan using PCR-based open-reading frame typing.
    Nakaie K; Yamada K; Kuwabara G; Imoto W; Yamairi K; Shibata W; Oshima K; Niki M; Sakurai N; Nonose Y; Okada Y; Fujita A; Kaneko Y; Kakeya H
    J Infect Chemother; 2021 Feb; 27(2):179-184. PubMed ID: 32950394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between statewide adoption of the CDC's Core Elements of Hospital Antimicrobial Stewardship Programs and rates of methicillin-resistant
    Garcia Reeves AB; Lewis JW; Trogdon JG; Stearns SC; Weber DJ; Weinberger M
    Infect Control Hosp Epidemiol; 2020 Apr; 41(4):430-437. PubMed ID: 31858919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections.
    Dubberke ER; Butler AM; Nyazee HA; Reske KA; Yokoe DS; Mayer J; Mangino JE; Khan YM; Fraser VJ;
    Clin Infect Dis; 2011 Jul; 53(1):20-5. PubMed ID: 21653298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries.
    Collins CE; Ayturk MD; Flahive JM; Emhoff TA; Anderson FA; Santry HP
    J Am Coll Surg; 2014 Jun; 218(6):1141-1147.e1. PubMed ID: 24755188
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Time trends and predictors of laboratory-confirmed recurrent and severe
    Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H
    CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Incidence, clinical characteristic and evolution of Clostridioides difficile infection].
    Jorge L; Azula N; Smayevsky J; Herrera F; Temporiti E; Bonvehí P
    Medicina (B Aires); 2021; 81(6):931-938. PubMed ID: 34875590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.